2型糖尿病与癌症之间关联的综述。
Review of Associations Between Type 2 Diabetes and Cancer.
作者信息
Bonagiri Pranay R, Shubrook Jay H
机构信息
Touro University California, Vallejo, CA.
出版信息
Clin Diabetes. 2020 Jul;38(3):256-265. doi: 10.2337/cd19-0077.
Abstract
Debate is ongoing regarding the relationship between type 2 diabetes and cancer, and the pathways linking the two are incompletely understood. Some posit that the relationship hinges on a common predisposing factor such as obesity, insulin resistance, or chronic inflammation that increases the risk of cancer independently. Others speculate that diabetes acts as an independent risk factor for cancer because of other molecular pathways and interactions. Additionally, antidiabetic medications have been associated with changes in cancer risk. This review presents a summary of the latest studies and data concerning the relationships among type 2 diabetes, antidiabetic medications, cancer risk, and cancer prognosis.
摘要
关于2型糖尿病与癌症之间的关系，目前仍在进行讨论，而连接两者的途径尚未完全明确。一些人认为，这种关系取决于共同的易感因素，如肥胖、胰岛素抵抗或慢性炎症，这些因素会独立增加患癌风险。另一些人则推测，糖尿病由于其他分子途径和相互作用，而成为癌症的独立危险因素。此外，抗糖尿病药物与癌症风险的变化有关。本综述总结了关于2型糖尿病、抗糖尿病药物、癌症风险和癌症预后之间关系的最新研究和数据。
相似文献
1
Review of Associations Between Type 2 Diabetes and Cancer.2型糖尿病与癌症之间关联的综述。
Clin Diabetes. 2020 Jul;38(3):256-265. doi: 10.2337/cd19-0077.
2
Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?糖尿病、抗高血糖药物与癌症风险：是烟还是火？
Curr Opin Endocrinol Diabetes Obes. 2013 Oct;20(5):485-94. doi: 10.1097/01.med.0000433065.16918.83.
3
Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain.2型糖尿病、抗糖尿病药物与结直肠癌风险：来自意大利和西班牙的两项病例对照研究
Front Oncol. 2016 Oct 6;6:210. doi: 10.3389/fonc.2016.00210. eCollection 2016.
4
Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'?炎症、胰岛素抵抗与2型糖尿病之间的关系：“因”还是“果”？
Curr Diabetes Rev. 2006 May;2(2):195-211. doi: 10.2174/157339906776818532.
5
Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors.糖尿病、抗糖尿病药物与 2 型糖尿病的癌症风险：关注 SGLT-2 抑制剂。
Int J Mol Sci. 2021 Feb 7;22(4):1680. doi: 10.3390/ijms22041680.
6
Vitamin D deficiency: a new risk factor for type 2 diabetes?维生素 D 缺乏：2 型糖尿病的新危险因素？
Ann Nutr Metab. 2012;61(4):337-48. doi: 10.1159/000342771. Epub 2012 Dec 3.
7
Diabetes and cancer, common threads and missing links.糖尿病与癌症：共同线索与缺失环节。
Cancer Lett. 2016 Apr 28;374(1):54-61. doi: 10.1016/j.canlet.2016.02.006. Epub 2016 Feb 12.
8
β-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKKβ/NF-κB and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.β-谷甾醇通过下调 2 型糖尿病大鼠脂肪细胞中 IKKβ/NF-κB 和 JNK 信号通路来规避肥胖引起的炎症和胰岛素抵抗。
Molecules. 2021 Apr 6;26(7):2101. doi: 10.3390/molecules26072101.
9
New insights in the molecular pathways linking obesity, type 2 diabetes and cancer.肥胖、2型糖尿病与癌症之间分子通路的新见解。
Rom J Morphol Embryol. 2019;60(4):1115-1125.
10
Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research.连接2型糖尿病和痴呆症的病理生理机制：临床、转化和流行病学研究证据综述
Curr Diabetes Rev. 2019;15(6):456-470. doi: 10.2174/1573399815666190129155654.
引用本文的文献
1
Microvascular Complications and Cancer Risk in Type 2 Diabetes: A Population-Based Study.2型糖尿病的微血管并发症与癌症风险：一项基于人群的研究。
Cancers (Basel). 2025 May 23;17(11):1760. doi: 10.3390/cancers17111760.
2
Triglyceride-glucose index in predicting gastric cancer prognosis: A need for caution.甘油三酯-葡萄糖指数在预测胃癌预后中的应用：需谨慎对待。
World J Gastroenterol. 2025 May 14;31(18):104525. doi: 10.3748/wjg.v31.i18.104525.
3
Identification of the shared gene signatures and biological mechanism in type 2 diabetes mellitus and hepatocellular carcinoma.2型糖尿病与肝细胞癌共同基因特征及生物学机制的鉴定
Clin Exp Hepatol. 2025 Mar;11(1):34-44. doi: 10.5114/ceh.2025.148439. Epub 2025 Mar 13.
4
Elevated PTPN3 expression in type 2 diabetes mellitus: Insights from genetic and experimental analyses.2型糖尿病中PTPN3表达升高：来自基因和实验分析的见解
Biomed Rep. 2025 Jan 27;22(3):53. doi: 10.3892/br.2025.1931. eCollection 2025 Mar.
5
Metformin may improve the outcome of patients with colorectal cancer and type 2 diabetes mellitus partly through effects on neutrophil extracellular traps.二甲双胍可能部分通过对中性粒细胞胞外诱捕网的作用来改善结直肠癌合并2型糖尿病患者的预后。
BJC Rep. 2023 Dec 12;1(1):20. doi: 10.1038/s44276-023-00022-w.
6
Cancer risk following onset of type 2 diabetes in New Zealanders with impaired glucose tolerance over 25 years: a matched prospective cohort study.25 年来，新西兰葡萄糖耐量受损的 2 型糖尿病患者发病后癌症风险：一项匹配的前瞻性队列研究。
BMC Cancer. 2024 Jul 24;24(1):892. doi: 10.1186/s12885-024-12637-4.
7
Associations between Diabetes Mellitus and Selected Cancers.糖尿病与某些癌症之间的关联。
Int J Mol Sci. 2024 Jul 8;25(13):7476. doi: 10.3390/ijms25137476.
8
Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management.肢端肥大症患者的糖尿病：病理生理学、临床挑战与管理
Nat Rev Endocrinol. 2024 Sep;20(9):541-552. doi: 10.1038/s41574-024-00993-x. Epub 2024 Jun 6.
9
Diabetes and further risk of cancer: a nationwide population-based study.糖尿病与癌症风险进一步增加：一项全国范围内基于人群的研究。
BMC Med. 2024 May 29;22(1):214. doi: 10.1186/s12916-024-03430-y.
10
Insulin Resistance: The Increased Risk of Cancers.胰岛素抵抗：癌症风险增加。
Curr Oncol. 2024 Feb 13;31(2):998-1027. doi: 10.3390/curroncol31020075.
本文引用的文献
1
9. Pharmacologic Approaches to Glycemic Treatment: .9. 血糖治疗的药物学方法： 。
Diabetes Care. 2020 Jan;43(Suppl 1):S98-S110. doi: 10.2337/dc20-S009.
2
The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis.糖尿病对子宫内膜癌风险的影响：一项更新的系统评价和荟萃分析。
BMC Cancer. 2019 May 31;19(1):527. doi: 10.1186/s12885-019-5748-4.
3
Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).降心血管事件 EXenatide 研究（EXSCEL）中血清降钙素浓度变化、甲状腺髓样癌发生率及常规降钙素浓度监测的影响。
Diabetes Care. 2019 Jun;42(6):1075-1080. doi: 10.2337/dc18-2028. Epub 2019 Apr 22.
4
Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis.胰高血糖素样肽-1 受体激动剂与胰腺癌：一项采用试验序贯分析的荟萃分析。
Sci Rep. 2019 Feb 20;9(1):2375. doi: 10.1038/s41598-019-38956-2.
5
Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity.二甲双胍通过抑制 ROS 生成和 NF-κB 活性抑制胆酸诱导的结直肠癌细胞白细胞介素 8 的上调。
Sci Rep. 2019 Feb 14;9(1):2003. doi: 10.1038/s41598-019-38778-2.
6
Metformin as a Therapeutic Target in Endometrial Cancers.二甲双胍作为子宫内膜癌的治疗靶点
Front Oncol. 2018 Aug 28;8:341. doi: 10.3389/fonc.2018.00341. eCollection 2018.
7
No pancreatic safety concern following glucagon-like peptide-1 receptor agonist therapies: A pooled analysis of cardiovascular outcome trials.GLP-1 受体激动剂治疗后无胰腺安全性担忧：心血管结局试验的汇总分析。
Diabetes Metab Res Rev. 2018 Nov;34(8):e3061. doi: 10.1002/dmrr.3061. Epub 2018 Sep 14.
8
Projection of the future diabetes burden in the United States through 2060.到2060年美国未来糖尿病负担的预测。
Popul Health Metr. 2018 Jun 15;16(1):9. doi: 10.1186/s12963-018-0166-4.
9
Pioglitazone and bladder cancer risk: a systematic review and meta-analysis.吡格列酮与膀胱癌风险：系统评价和荟萃分析。
Cancer Med. 2018 Apr;7(4):1070-1080. doi: 10.1002/cam4.1354. Epub 2018 Feb 24.
10
Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and acute pancreatitis: A meta-analysis with trial sequential analysis.二肽基肽酶-4 抑制剂、胰腺癌和急性胰腺炎：一项荟萃分析与试验序贯分析。
Sci Rep. 2018 Jan 15;8(1):782. doi: 10.1038/s41598-017-19055-6.
Zotero 插件